Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (2255)	3/28/2005 1:35:44 PM
From: nigel bates	Read Replies (1) \| Respond to of 12215

What might Ligand be worth to, say, GSK ?

To: scaram(o)uche who wrote (2255)	3/28/2005 3:40:53 PM
From: zeta1961	Read Replies (1) \| Respond to of 12215

The quarter of living dangerously.. I bought some Aria and put an order to add to MYGN..the latter has upcoming news and they can't comply with official audit committee rules..now that's very scary with this company(completely sarcastic)..and funds now shorting all upcoming bio-events? Obvious to folk here but shows me again, the retailor does not a market make? DNDN could be an interesting momo..close to 50%float is short..timing is tricky..not up for it yet.. Edited for spelling corrections Zeta